LD-2 disclosure · 2nd Quarter - Report
KALEO
Client
- Name
- KALEO
- Description
- Pharmaceutical development and manufacturing
- Location
- Virginia · United States of America
Registrant
- Description
- Government relations firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
5 issuesAviation/Airlines/Airports
FAA reauthorization provisions related to emergency medicine.
LobbyistsROBERT ZUCKER · SCOTT MACKENZIE · CHELSEY PENROD HICKMAN · CHARLA PENN
Covered position (ROBERT ZUCKER): LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg
Covered position (SCOTT MACKENZIE): Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)
Covered position (CHELSEY PENROD HICKMAN): CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
Covered position (CHARLA PENN): LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Legislation related to prescription drug prices, including the implementation of Inflation Reduction Act (IRA); access to epinephrine in schools and other community settings
LobbyistsROBERT ZUCKER · SCOTT MACKENZIE · CHELSEY PENROD HICKMAN · CHARLA PENN
Covered position (ROBERT ZUCKER): LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg
Covered position (SCOTT MACKENZIE): Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)